{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:08:43Z","timestamp":1784549323065,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urolonc.2025.12.016","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:28:00Z","timestamp":1768829280000},"page":"110980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA NPSR1-AS1 affects the malignant biological behavior of bladder cancer through miR-199a-3p and the clinical value of urine-derived lncRNA NPSR1-AS1"],"prefix":"10.1016","volume":"44","author":[{"given":"Weijing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8145-6760","authenticated-orcid":false,"given":"Yong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.12.016_bib0001","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.euf.2020.02.012","article-title":"Bladder cancer: advances and innovations","volume":"6","author":"Daneshmand","year":"2020","journal-title":"Europ Urol Focus"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12894-025-01760-4","article-title":"Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0004","article-title":"The application of 3D bioprinting in urological diseases","volume":"16","author":"Xu","year":"2022","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0044-1788614","article-title":"ABO blood type and urinary bladder cancer: phenotype, genotype, allelic association with a clinical or histological stage and recurrence rate","volume":"11","author":"Milas","year":"2024","journal-title":"Global Med Genet"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610282","article-title":"A novel prognostic factor TIPE2 in bladder cancer","volume":"28","author":"Jiang","year":"2022","journal-title":"Pathol Oncol Res: POR"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0007","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21037\/tau-22-704","article-title":"Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx","volume":"12","author":"Kim","year":"2023","journal-title":"Translat Androl Urol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2535774","article-title":"NR4A3 regulates anoikis resistance and metastasis of bladder cancer through EWSR1","volume":"26","author":"Fan","year":"2025","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0009","article-title":"Application of immune checkpoint inhibitors in cancer","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12672-024-01570-4","article-title":"Advances in irreversible electroporation for prostate cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Disc Oncol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0011","doi-asserted-by":"crossref","first-page":"180","DOI":"10.23736\/S2724-6051.22.04953-9","article-title":"Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG","volume":"75","author":"Contieri","year":"2023","journal-title":"Minerv Urol Nephrol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0012","doi-asserted-by":"crossref","first-page":"812","DOI":"10.21037\/tau-23-469","article-title":"Exploring the microRNA-mRNA regulatory network associated with solasonine in bladder cancer","volume":"13","author":"Fang","year":"2024","journal-title":"Translat Androl Urol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/bios13010106","article-title":"Recent progress in nanomaterial-based biosensors and theranostic nanomedicine for bladder cancer","volume":"13","author":"Song","year":"2023","journal-title":"Biosensors."},{"key":"10.1016\/j.urolonc.2025.12.016_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2018.05.014","article-title":"Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis","volume":"36","author":"Vartolomei","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0015","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1080\/21655979.2022.2062088","article-title":"Long non-coding RNAs PGM5-AS1 upregulates decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0016","doi-asserted-by":"crossref","unstructured":"Zhou L., Huang X., Li H., Wang J., Lu Z. Triptolide improves Alzheimer's disease by regulating the NF\u2011\u03bab signaling pathway through the lncRNA NEAT1\/microRNA 361\u20113p\/TRAF2 axis. Experimental and therapeutic medicine. 2023;26:440.https:\/\/doi.org\/10.3892\/etm.2023.12139.","DOI":"10.3892\/etm.2023.12139"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0017","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","article-title":"LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Comms"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41419-020-02840-z","article-title":"LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13046-023-02774-2","article-title":"LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a\/RREB1 positive feedback loop and a ceRNA network","volume":"42","author":"Dong","year":"2023","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136579","article-title":"LncRNA MACC1-AS1 facilitates the cell growth of small cell lung cancer by sequestering miR-579-3p and mediating NOTCH1-pathway","volume":"281","author":"Hong","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0021","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.urolonc.2020.02.016","article-title":"Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Gu\u00e9rin after transurethral resection of the bladder tumor","volume":"38","author":"Ferro","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0022","doi-asserted-by":"crossref","unstructured":"Seidl C. Targets for therapy of bladder cancer. Seminars in nuclear medicine. 2020;50:162\u201370.https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.02.006.","DOI":"10.1053\/j.semnuclmed.2020.02.006"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41585-024-00857-z","article-title":"Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence","volume":"21","author":"Zhang","year":"2024","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0024","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00345-018-2567-1","article-title":"Diagnostic biomarkers in non-muscle invasive bladder cancer","volume":"37","author":"Faiena","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0025","article-title":"Alternative splicing regulation and its therapeutic potential in bladder cancer","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0026","article-title":"Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: myosin light chain kinase and caldesmon","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15384101.2021.1979773","article-title":"NPSR1-AS1 activates the MAPK pathway to facilitate thyroid cancer cell malignant behaviors via recruiting ELAVL1 to stabilize NPSR1 mRNA","volume":"21","author":"Ni","year":"2022","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0028","doi-asserted-by":"crossref","unstructured":"He H., Chen T., Mo H., Chen S., Liu Q., Guo C. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK\/ERK pathway. Biochemical and biophysical research communications. 2020;533:886\u201392.https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.076.","DOI":"10.1016\/j.bbrc.2020.09.076"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CAD.0000000000000983","article-title":"miR-199a-3p suppresses progression of esophageal squamous cell carcinoma through inhibiting mTOR\/p70S6K pathway","volume":"32","author":"Hou","year":"2021","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0030","first-page":"2163","article-title":"miR\u2011199a\u20113p\/Sp1\/LDHA axis controls aerobic glycolysis in testicular tumor cells","volume":"42","author":"Zhou","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110636","article-title":"miR-199a-3p promotes gastric cancer progression by promoting its stemness potential via DDR2 mediation","volume":"106","author":"Ren","year":"2023","journal-title":"Cell Signall"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0032","first-page":"2252","article-title":"miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy","volume":"6","author":"Ecke","year":"2017","journal-title":"Ca Med"},{"key":"10.1016\/j.urolonc.2025.12.016_bib0033","article-title":"Combination of urine exosomal mRNAs and lncRNAs as novel diagnostic biomarkers for bladder cancer","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:51:06Z","timestamp":1784548266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078143925004995"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA NPSR1-AS1 affects the malignant biological behavior of bladder cancer through miR-199a-3p and the clinical value of urine-derived lncRNA NPSR1-AS1","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110980"}}